Healthtech VC aMoon drops $6M on Nectin Therapeutics's immunotherapy treatment
Dor Schwartz
aMoon realizes the immense potential of the Israeli startup's immuno-oncology biotherapy treatment for cancer, with a $6M investment that is expected to grow to $15M......